251 related articles for article (PubMed ID: 32540889)
1. Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis.
Kamiya H; Panlaqui OM
BMJ Open; 2020 Jun; 10(6):e035420. PubMed ID: 32540889
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis.
Kamiya H; Panlaqui OM
BMJ Open; 2019 May; 9(5):e028226. PubMed ID: 31129597
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2020 Mar; 20(1):57. PubMed ID: 32122329
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features.
Kamiya H; Panlaqui OM
BMJ Open; 2019 Dec; 9(12):e031444. PubMed ID: 31831537
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease.
Kamiya H; Panlaqui OM; Izumi S; Sozu T
BMJ Open; 2018 Dec; 8(12):e023998. PubMed ID: 30559160
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2021 May; 21(1):150. PubMed ID: 33952218
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.
Kamiya H; Panlaqui OM
BMJ Open; 2019 May; 9(5):e027849. PubMed ID: 31147365
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.
Cao MS; Sheng J; Wang TZ; Qiu XH; Wang DM; Wang Y; Xiao YL; Cai HR
Chin Med J (Engl); 2019 Sep; 132(18):2177-2184. PubMed ID: 31490258
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Kang HS; Cho KW; Kwon SS; Kim YH
Respirology; 2018 Feb; 23(2):206-212. PubMed ID: 29024319
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
17. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Suzuki T; Hozumi H; Miyashita K; Kono M; Suzuki Y; Karayama M; Furuhashi K; Hasegawa H; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Yokomura K; Nakamura H; Suda T
Sci Rep; 2021 Apr; 11(1):9120. PubMed ID: 33907284
[TBL] [Abstract][Full Text] [Related]
18. Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
He X; Ji J; Liu C; Luo Z; Tang J; Yan H; Guo L
Ann Med; 2024 Dec; 56(1):2311845. PubMed ID: 38301276
[TBL] [Abstract][Full Text] [Related]
19. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
20. The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
PLoS One; 2019; 14(8):e0212810. PubMed ID: 31425562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]